We have discovered that short
![](/images/gifchars/beta2.gif)
-peptides (9 or 10 residues) designed to adopt globally amphiphilic helical conformations display significant antifungal activity. The most promising
![](/images/gifchars/beta2.gif)
-peptides cause little lysis of human red blood cells at concentrations that kill
Candida albicans, a common human fungal pathogen. Since fungi are eukaryotes, discrimination between fungal and human cells is a significant finding. Our
![](/images/gifchars/beta2.gif)
-peptides are active under assay conditions that mimic physiological ionic strength; in contrast,
![](/images/gifchars/alpha.gif)
-helix-forming host-defense
![](/images/gifchars/alpha.gif)
-peptides are inactive against
C. albicans under these conditions.